The Pennsylvania Department of Health released a health advisory on October 4, 2022. Below is a summary:
Severe Manifestations of Monkeypox among People who are Immunocompromised Due to HIV or Other Conditions
- Severe manifestations of monkeypox have been observed in the United States in the current outbreak.
- People who are immunocompromised due to HIV or other conditions are at higher risk for severe manifestations of monkeypox than people who are immunocompetent.
- Because people with HIV-associated immunocompromise are at risk for severe manifestations of monkeypox, the HIV status of all sexually active adults and adolescents with suspected or confirmed monkeypox should be determined.
- There are diagnostic and clinical management strategies that may help address severe manifestations of monkeypox including: oral and intravenous tecovirimat (TPOXX), cidofovir or brincidofovir, and vaccinia immune globulin intravenous (VIGIV).
- Contact your local health department or the PA Department of Health (PADOH) at 717-787-3350, when there is concern for progression to severe manifestations or severe manifestations are present for guidance on management and securing necessary resources for treatment.